查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球糖組學市場，到 2030 年的市場預測：按產品、用途、最終用戶和地區進行的全球分析
市場調查報告書
商品編碼
1372016

全球糖組學市場，到 2030 年的市場預測：按產品、用途、最終用戶和地區進行的全球分析

Glycomics Market Forecasts to 2030 - Global Analysis By Product (Kits, Reagents, Enzymes and Instruments), Application (Diagnostics, Drug Discovery & Development and Other Applications), End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球糖組學市場規模為 21.3 億美元，預計到 2030 年將達到 66.1 億美元，預測期內年複合成長率為 17.5%。

糖組學是分子生物學和生物化學的一個領域，專注於生命系統中碳水化合物（糖）的結構、功能和生物學的綜合分析。它涉及複雜碳水化合物（稱為聚醣）及其與細胞和生物體中其他分子的相互作用的研究。該研究具有廣泛的意義，包括了解生物過程、闡明疾病機制和開發新的治療方法。

哥本哈根大學糖組學中心的研究人員在 2022 年 2 月發表的一項研究表明，醣組學研究使得在不使用動物的情況下生產肝素成為可能。

糖組學研究的興起

越來越多的糖組學研究揭示了聚醣在各種生物過程、疾病和治療開發中的重要作用。這種廣泛的範圍正在為跨生物醫學應用的糖組學技術創造更廣泛的市場。糖組學研究的增加促進了分析技術的創新。隨著研究的不斷增加，對更容易獲得和更具成本效益的糖組學技術的需求不斷成長。它還創造了對專業工具、技術和服務的強勁需求。這些方面正在推動市場成長。

有限的標準化

聚醣是高度多樣化且結構複雜的分子。在不同的研究環境和實驗室中標準化聚醣分析和表徵非常困難，並且可能導致資料解釋中潛在的不一致和困難。此外，有限的商業性標準、多樣化的分析技術、環境要素、結構多樣性和演化多樣性阻礙了市場需求。

癌症生物標記和診斷的增加

醣組學研究在識別與不同類型癌症相關的特異性聚醣結構方面發揮著重要作用。了解這些獨特的聚醣模式有助於開發準確可靠的癌症生物標記。這提高了癌症亞型分類的準確性。醣組學研究也可能導致發現與特定癌症類型相關的多種聚醣生物標記。透過將這些標記物組合成一個群組，可以進一步提高診斷準確性。此外，改善癌症檢測、治療和患者治療結果的實際意義正在推動市場成長。

設備和試劑高成本

研究機構，尤其是預算有限的研究和學術機構，在取得和維護必要的糖組學設備和試劑方面可能面臨挑戰。這減慢了研究的步伐，甚至讓一些實驗室對於進入該領域猶豫不決。設備和試劑的高成本也可能阻礙公司和製造商投資糖組學技術的研發。因此，高昂的進入成本可能會減緩糖組學市場的成長。

COVID-19 的影響

COVID-19大流行對糖組學領域產生了直接和間接的影響。由於關閉、限制和安全措施，許多實驗室和研究機構的業務面臨中斷。大流行的經濟影響對研究經費產生了長期影響。從正面的一面來看，這場大流行凸顯了了解聚醣在病毒感染中的作用的重要性。研究人員正在探索聚醣在開發與 COVID-19 相關的療法、疫苗或診斷方面的潛力。

預計套件細分市場在預測期內將是最大的

套件領域預計將出現良好的成長。糖組學試劑盒是專門的試劑、工具和方案集，旨在促進生物檢體中複雜碳水化合物（聚醣）的分析和研究。我們提供一套標準化試劑和方法，用於全面分析生物檢體中的聚醣。醣組學試劑盒包含酵素、標記劑以及酵素釋放和修飾聚醣以進行詳細結構分析所需的其他工具。這些在生物製藥的診斷和品管中發揮著重要作用。

預計藥物研發和開發領域在預測期內的年複合成長率最高。

在預測期內，藥物研發和開發領域預計將以最高年複合成長率成長。將糖組學整合到藥物研發和開發過程中可以實現更準確、更有效的治療，透過改善治療結果和最大限度地減少副作用最終使患者受益。糖組學有助於藥物設計，減少脫靶效應並提高選擇性。它還可以提高疫苗效率。所有這些要素都在推動該領域的成長。

比最大的地區

預計北美在預測期內將佔據最大的市場佔有率。北美由美國和加拿大結構，是世界上最大的糖組市場之一。北美擁有許多著名的研究機構、大學和學術醫療中心。該地區先進的醫療保健基礎設施、強大的研究生態系統以及對生物技術和生命科學的大量投資正在促進市場的規模和成長。

複合年複合成長率最高的地區

預計亞太地區在預測期內的年複合成長率最高。亞太糖組學市場是全球生物技術公司、學術研究機構和本地製造商的混合體。老牌企業和新興新興企業都在為競爭形勢做出貢獻。亞太地區的生物製藥產業正在迅速擴張。醫療保健產業向個人化醫療的轉變正在推動該地區對糖組學技術的需求。

提供免費客製化

訂閱此報告的客戶可以利用以下免費自訂選項之一：

  • 公司簡介
    • 其他市場公司的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 利害關係人
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究來源
    • 主要研究來源
    • 二次研究來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球糖組學市場：依產品

  • 成套工具
    • 聚醣標記試劑盒
    • 聚醣精製盒
    • 聚醣釋放套件
    • 其他糖組學試劑盒
  • 試劑
    • 糖蛋白
    • 單醣
    • 寡糖
    • 其他試劑
  • 酵素
    • 糖苷酶
    • 糖基轉移酶
    • 神經氨酸酶
    • 唾液酸轉移酶
    • 其他酵素
  • 裝置
    • 高效液相層析（HPLC）
    • 基質輔助雷射解吸/電離飛行時間(MALDI-TOF)
    • 質譜儀
    • 陣列系統
    • 其他設備

第6章 全球糖組學市場：依用途

  • 診斷
  • 藥物研發/開發
  • 其他用途

第7章 全球糖組學市場：依最終用戶分類

  • 學術研究所
  • 製藥和生物技術公司
  • 生物製藥公司
  • 合約研究組織（CRO）

第8章 全球糖組學市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東/非洲

第9章 進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章 公司簡介

  • Asparia Glycomics
  • Merck KGaA
  • Bruker
  • Thermo Fisher Scientific, Inc
  • New England Biolabs
  • Waters Corporation
  • Takara Bio Inc
  • Agilent Technologies Inc.
  • RayBiotech Life, Inc.
  • Shimadzu Corporation
  • Danaher
  • Lectenz Bio
  • Intellihep Limited
  • Sanofi Corporation
  • Bayer AG
Product Code: SMRC24072

According to Stratistics MRC, the Global Glycomics Market is accounted for $2.13 billion in 2023 and is expected to reach $6.61 billion by 2030 growing at a CAGR of 17.5% during the forecast period. Glycomics is a field of study within molecular biology and biochemistry that focuses on the comprehensive analysis of the structure, function, and biology of carbohydrates (sugars) in biological systems. It involves the study of complex carbohydrates, also known as glycans, and their interactions with other molecules in cells and organisms. Its research has far-reaching implications for understanding of biological processes, disease mechanisms, and the development of novel therapies.

According to a study published in February 2022 by researchers at the University of Copenhagen's Center for Glycomics, Heparin can now be produced without using animals through glycomics studies.

Market Dynamics:

Driver:

Increasing research in glycomics

Growing research in glycomics reveals the critical role of glycans in various biological processes, diseases, and therapeutic development. This broadening scope creates a wider market for glycomics technologies across biomedicine applications. Increased research in glycomics fosters innovation in analytical techniques. With increased research, there is a demand for more accessible and cost-effective glycomics technologies. It also creates a strong demand for specialized tools, technologies, and services. These aspects are propelling the market growth.

Restraint:

Limited standardization

Glycans are highly diverse and structurally complex molecules. Standardizing the analysis and characterization of glycans across different research settings and laboratories can be challenging, leading to potential inconsistencies and difficulties in data interpretation. In addition, its limited commercial standards, varied analytical techniques, environmental factors, structural diversity and evolutionary variabilites hinder the market demand.

Opportunity:

Rising cancer biomarkers and diagnostics

Glycomics research plays a crucial role in identifying specific glycan structures associated with various types of cancer. Understanding these unique glycan patterns allows for the development of accurate and reliable cancer biomarkers. It improves precision in cancer subtyping. Also, glycomics research may lead to the discovery of multiple glycan biomarkers associated with a specific cancer type. Combining these markers into a panel can further enhance diagnostic accuracy. Further, its practical implications for improving cancer detection, treatment, and patient outcomes are accelerating the market growth.

Threat:

High cost of instruments and reagents

Research labs, particularly those with limited budgets or in academic settings, may face challenges in acquiring and maintaining the necessary glycomics equipment and reagents. This can lead to a slower pace of research or even deter some labs from entering the field. The high cost of instruments and reagents may deter companies and manufacturers from investing in research and development for glycomics technologies. Therefore, the high cost of entry can potentially slow down the growth of the glycomics market.

COVID-19 Impact

The COVID-19 pandemic had both direct and indirect impacts on the field of Glycomics. Many research laboratories and institutions faced disruptions in their operations due to lockdowns, restrictions, and safety measures. The financial impact of the pandemic had a long-term effect on research funding. On the positive side, the pandemic highlighted the importance of understanding the role of glycans in viral infections. Researchers have explored the potential of glycans in the development of therapeutics, vaccines, or diagnostics related to COVID-19.

The kits segment is expected to be the largest during the forecast period

The kits segment is estimated to have a lucrative growth. Glycomics kits are specialized sets of reagents, tools, and protocols designed to facilitate the analysis and study of complex carbohydrates (glycans) in biological samples. They provide a standardized set of reagents and methods for the comprehensive profiling of glycans in biological samples. Glycomics kits include enzymes, labeling agents, and other tools necessary for the enzymatic release and modification of glycans, enabling detailed structural analysis. They play a crucial role in the diagnostics and quality control in biopharmaceuticals.

The drug discovery & development segment is expected to have the highest CAGR during the forecast period

The drug discovery & development segment is anticipated to witness the highest CAGR growth during the forecast period. The integration of glycomics into drug discovery and development processes leads to more precise and effective therapies, ultimately benefiting patients by improving treatment outcomes and minimizing side effects. Glycomics can contribute to the design of drugs with reduced off-target effects and improved selectivity. It can also improve vaccine efficiency. All these factors are driving the segment growth.

Region with largest share:

North America is projected to hold the largest market share during the forecast period. North America, comprising the United States and Canada, represented one of the largest glycomics markets globally. North America is home to numerous prominent research institutions, universities, and academic medical centers. The region's advanced healthcare infrastructure, robust research ecosystem, and significant investments in biotechnology and life sciences contributed to the market's size and growth.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period. The Glycomics market in Asia Pacific includes a mix of global biotechnology companies, academic research institutions, and local manufacturers. Both established players and emerging start-ups contribute to the competitive landscape. The biopharmaceutical industry in Asia Pacific is expanding rapidly. The shift towards personalized medicine in the healthcare industry drives the demand for glycomics technologies in this region.

Key players in the market:

Some of the key players profiled in the Glycomics Market include: Asparia Glycomics, Merck KGaA, Bruker, Thermo Fisher Scientific, Inc, New England Biolabs, Waters Corporation, Takara Bio Inc, Agilent Technologies Inc., RayBiotech Life, Inc., Shimadzu Corporation, Danaher, Lectenz Bio, Intellihep Limited, Sanofi Corporation and Bayer AG.

Key Developments:

In August 2023, Thermo Fisher Scientific the world leader in serving science, announced the commercial launch of the EXENT® Solution, after receiving IVDR certification*. The EXENT solution is a fully integrated and automated mass spectrometry system designed to transform diagnosis and assessment for patients with monoclonal gammopathies.

In June 2022, Sanofi announced the launch of its first Digital Accelerator to foster its ambition to become a leading digital healthcare company. The Accelerator will develop products and solutions that will support Sanofi's mission to transform the practice of medicine with the use of digital, data and artificial intelligence (AI).

Products Covered:

  • Kits
  • Reagents
  • Enzymes
  • Instruments

Applications Covered:

  • Diagnostics
  • Drug Discovery & Development
  • Other Applications

End Users Covered:

  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Biopharmaceutical Companies
  • Contract Research Organization (CRO)

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Glycomics Market, By Product

  • 5.1 Introduction
  • 5.2 Kits
    • 5.2.1 Glycan Labeling Kits
    • 5.2.2 Glycan Purification Kits
    • 5.2.3 Glycan Release Kits
    • 5.2.4 Other Glycomics Kits
  • 5.3 Reagents
    • 5.3.1 Glycoproteins
    • 5.3.2 Monosaccharides
    • 5.3.3 Oligosaccharides
    • 5.3.4 Other Reagents
  • 5.4 Enzymes
    • 5.4.1 Glycosidases
    • 5.4.2 Glycosyltransferases
    • 5.4.3 Neuraminidases
    • 5.4.4 Sialyltransferases
    • 5.4.5 Other Enzymes
  • 5.5 Instruments
    • 5.5.1 High-Performance Liquid Chromatography (HPLC)
    • 5.5.2 Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight (MALDI-TOF)
    • 5.5.3 Mass Spectrometers
    • 5.5.4 Array Systems
    • 5.5.5 Other Instruments

6 Global Glycomics Market, By Application

  • 6.1 Introduction
  • 6.2 Diagnostics
  • 6.3 Drug Discovery & Development
  • 6.4 Other Applications

7 Global Glycomics Market, By End User

  • 7.1 Introduction
  • 7.2 Academic & Research Institutes
  • 7.3 Pharmaceutical & Biotechnology Companies
  • 7.4 Biopharmaceutical Companies
  • 7.5 Contract Research Organization (CRO)

8 Global Glycomics Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Asparia Glycomics
  • 10.2 Merck KGaA
  • 10.3 Bruker
  • 10.4 Thermo Fisher Scientific, Inc
  • 10.5 New England Biolabs
  • 10.6 Waters Corporation
  • 10.7 Takara Bio Inc
  • 10.8 Agilent Technologies Inc.
  • 10.9 RayBiotech Life, Inc.
  • 10.10 Shimadzu Corporation
  • 10.11 Danaher
  • 10.12 Lectenz Bio
  • 10.13 Intellihep Limited
  • 10.14 Sanofi Corporation
  • 10.15 Bayer AG

List of Tables

  • Table 1 Global Glycomics Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Glycomics Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Glycomics Market Outlook, By Kits (2021-2030) ($MN)
  • Table 4 Global Glycomics Market Outlook, By Glycan Labeling Kits (2021-2030) ($MN)
  • Table 5 Global Glycomics Market Outlook, By Glycan Purification Kits (2021-2030) ($MN)
  • Table 6 Global Glycomics Market Outlook, By Glycan Release Kits (2021-2030) ($MN)
  • Table 7 Global Glycomics Market Outlook, By Other Glycomics Kits (2021-2030) ($MN)
  • Table 8 Global Glycomics Market Outlook, By Reagents (2021-2030) ($MN)
  • Table 9 Global Glycomics Market Outlook, By Glycoproteins (2021-2030) ($MN)
  • Table 10 Global Glycomics Market Outlook, By Monosaccharides (2021-2030) ($MN)
  • Table 11 Global Glycomics Market Outlook, By Oligosaccharides (2021-2030) ($MN)
  • Table 12 Global Glycomics Market Outlook, By Other Reagents (2021-2030) ($MN)
  • Table 13 Global Glycomics Market Outlook, By Enzymes (2021-2030) ($MN)
  • Table 14 Global Glycomics Market Outlook, By Glycosidases (2021-2030) ($MN)
  • Table 15 Global Glycomics Market Outlook, By Glycosyltransferases (2021-2030) ($MN)
  • Table 16 Global Glycomics Market Outlook, By Neuraminidases (2021-2030) ($MN)
  • Table 17 Global Glycomics Market Outlook, By Sialyltransferases (2021-2030) ($MN)
  • Table 18 Global Glycomics Market Outlook, By Other Enzymes (2021-2030) ($MN)
  • Table 19 Global Glycomics Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 20 Global Glycomics Market Outlook, By High-Performance Liquid Chromatography (HPLC) (2021-2030) ($MN)
  • Table 21 Global Glycomics Market Outlook, By Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight (MALDI-TOF) (2021-2030) ($MN)
  • Table 22 Global Glycomics Market Outlook, By Mass Spectrometers (2021-2030) ($MN)
  • Table 23 Global Glycomics Market Outlook, By Array Systems (2021-2030) ($MN)
  • Table 24 Global Glycomics Market Outlook, By Other Instruments (2021-2030) ($MN)
  • Table 25 Global Glycomics Market Outlook, By Application (2021-2030) ($MN)
  • Table 26 Global Glycomics Market Outlook, By Diagnostics (2021-2030) ($MN)
  • Table 27 Global Glycomics Market Outlook, By Drug Discovery & Development (2021-2030) ($MN)
  • Table 28 Global Glycomics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 29 Global Glycomics Market Outlook, By End User (2021-2030) ($MN)
  • Table 30 Global Glycomics Market Outlook, By Academic & Research Institutes (2021-2030) ($MN)
  • Table 31 Global Glycomics Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
  • Table 32 Global Glycomics Market Outlook, By Biopharmaceutical Companies (2021-2030) ($MN)
  • Table 33 Global Glycomics Market Outlook, By Contract Research Organization (CRO) (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.